Evolutionary Genomics Inc (FNAM)
0.0008
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Evolutionary Genomics Total Liabilities (Quarterly): 7.946M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 7.946M |
September 30, 2022 | 7.926M |
June 30, 2022 | 7.861M |
March 31, 2022 | 7.824M |
December 31, 2021 | 7.332M |
September 30, 2021 | 7.353M |
June 30, 2021 | 6.021M |
March 31, 2021 | 5.896M |
December 31, 2020 | 5.819M |
September 30, 2020 | 4.626M |
June 30, 2020 | 4.931M |
March 31, 2020 | 4.690M |
December 31, 2019 | 4.576M |
September 30, 2019 | 4.545M |
June 30, 2019 | 4.546M |
March 31, 2019 | 4.041M |
December 31, 2018 | 3.985M |
September 30, 2018 | 0.9568M |
June 30, 2018 | 0.958M |
March 31, 2018 | 3.995M |
December 31, 2017 | 3.996M |
September 30, 2017 | 4.540M |
June 30, 2017 | 4.527M |
March 31, 2017 | 4.750M |
December 31, 2016 | 4.561M |
Date | Value |
---|---|
September 30, 2016 | 3.104M |
June 30, 2016 | 3.009M |
March 31, 2016 | 3.020M |
December 31, 2015 | 0.2538M |
September 30, 2015 | 0.0459M |
June 30, 2015 | 0.0361M |
March 31, 2015 | 0.0312M |
December 31, 2014 | 1.518M |
September 30, 2014 | 0.0086M |
June 30, 2014 | 0.0001M |
March 31, 2014 | 0.0791M |
December 31, 2013 | 0.0782M |
September 30, 2013 | 0.0756M |
June 30, 2013 | 0.0736M |
March 31, 2013 | 0.0654M |
December 31, 2012 | 0.0633M |
September 30, 2012 | 0.06M |
June 30, 2012 | 0.0579M |
March 31, 2012 | 0.0562M |
December 31, 2011 | 0.0489M |
September 30, 2011 | 0.0465M |
June 30, 2011 | 0.0405M |
March 31, 2011 | 0.0387M |
December 31, 2010 | 0.0315M |
September 30, 2010 | 0.0251M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.576M
Minimum
Dec 2019
7.946M
Maximum
Dec 2022
6.369M
Average
6.021M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 2.376M |
FluoroPharma Medical Inc | 10.51M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 2.406M |
Regenerx Biopharmaceuticals Inc | 3.931M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.354M |
Shareholders Equity (Quarterly) | -5.592M |